Literature DB >> 23302028

Investigation of cardiac autonomic and peripheral sensory neuropathy in diabetic and nondiabetic patients with hypertension.

Peter Legrady1, Dora Bajcsi, Csaba Lengyel, Tamas T Varkonyi, Imola Fejes, Peter Kempler, Gyorgy Abraham.   

Abstract

Peripheral sensory function and cardiac autonomic neuropathy were studied in 18 nondiabetic and 10 type-2 diabetic hypertensives compared with 11 healthy controls. All the patients were treated with antihypertensive drugs. Cardiac autonomic neuropathy using Ewing method was detected in all patient groups. The current perception threshold values on peroneal nerve at 250 Hz in nondiabetic group and at 250 Hz and at 5 Hz in diabetic group were found increased compared with the controls. In conclusion, so-called typical complications of diabetes can be observed in nondiabetic hypertensives also. Our data might support the essential role of vascular factors in the development of neuropathy.

Entities:  

Mesh:

Year:  2013        PMID: 23302028     DOI: 10.3109/10641963.2012.758272

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  3 in total

1.  Assessment of sudomotor function in hypertensive with/without type-2 diabetes patients using SUDOSCAN: An electrophysiological study.

Authors:  Ismail Ibrahim Hussein; Safaa Hussein Ali Alshammary; Marwan S M Al-Nimer
Journal:  Clin Neurophysiol Pract       Date:  2020-12-13

2.  Assessment of diabetic polyneuropathy and autonomic neuropathy using current perception threshold in korean patients with diabetes mellitus.

Authors:  Bo Kyung Koo; Jung Hun Ohn; Soo-Heon Kwak; Min Kyong Moon
Journal:  Diabetes Metab J       Date:  2014-08-20       Impact factor: 5.376

3.  Median Nerve Affection in Hypertensive Patients with and without Diabetes High-Resolution Ultrasound Assessment.

Authors:  Ahmed Esmat; Mahmoud I Elshamy; Doaa Mohamed Zakaria; Zakarya Shady; Eman Roshdy Mohamed; Nashwa El-Khouly; Marwa M Hassan; Fatma M El-Senosy
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-15       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.